Publication,

Impact of COVID-19 on Private Funds - One Year On

Current site :    HK   |   EN
Australia
Belgium
China
China Hong Kong SAR
Germany
Italy
Japan
Singapore
Spain
UAE
United Kingdom
United States
Global
In April 2020, shortly after COVID-19 was declared a pandemic by the World Health Organisation, we published the "Impact of COVID-19 on Private Fundraisings, Comparisons to GFC and Looking Ahead" article, which summarised the fundraising environment at that time. Much has changed since then even though COVID-19 itself has not yet been defeated.
 
In summary, the pandemic did not adversely impact fundraising activity of private funds as much as many people had expected. 
 
In this article, we discuss the current state of events at a macro level by looking at the general economic climate before delving into specific areas of fundraising. This will follow with our view on secondaries, dry powder, deals, valuations and returns, and the outlook for 2021.
DOWNLOAD PUBLICATION
Impact of COVID-19 on Private Funds – One Year On

Download

2.9MB, 19 Pages

LATEST THINKING
Insight
New regulations in China designed to encourage innovation in clinical trials have made it easier to test human samples in a lab setting.

19 May 2022

Insight
On 5 May 2022, the Hong Kong Monetary Authority (HKMA) announced the launch of the Mandatory Reference Checking Scheme (MRC Scheme), including the implementing guidelines issued by the Hong Kong Association of Banks (HKAB) and the DTC Association (Guidelines). The Guidelines seek to redress the “rolling bad apples” phenomenon in Hong Kong’s banking sector. That is, they seek to prevent individuals involved in misconduct from moving from one authorised institution (AI) to another. In this alert, we summarise the key features of the MRC Scheme. We also briefly summarise the matters that have been of particular interest to AIs.

11 May 2022